logo

Diseases and Drugs

Share

bavarian nordic 052722 As another month comes to a close, it's time to take a look back at some of the healthcare sector news that made headlines in May and look ahead to what's in store on the regulatory front in June.

fda aprl27 The FDA decision on Amicus Therapeutics' (FOLD) New Drug Application for Miglustat, one of the two components of AT-GAA, proposed for adult patients with Pompe disease, is slated for May 29.

fda march28 An FDA panel is scheduled to review TG Therapeutics Inc.'s (TGTX) Biologics License Application/supplemental New Drug Application for the combination of Ublituximab and Ukoniq, known as the U2 regimen, on April 22, 2022. The U2 regimen is proposed for the treatment of adult patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

fda feb25 As another month comes to an end, it's time to take a look back at some of the regulatory news that made headlines in February and look ahead to what the month of March has in store.

solensiaomicorn 0125 In January, 2 novel drugs received the regulatory nod in the U.S., and they are Swiss biotech Idorsia Ltd.'s Quviviq to treat insomnia and Pfizer's Cibinqo to treat refractory, moderate-to-severe atopic dermatitis. Now, let's take a look at the biotech stocks facing FDA decision in February.

fda dec27 As another month comes to an end, we take a look back at some of the regulatory news that dominated the headlines in December and look ahead to what's in store for January.

podiumrankings dec22 Prevention is always better than cure. The year 2021 saw the global rollout of vaccines being accelerated for the prevention of a new disease. Yes, a disease that has been dominating the headlines since 2020 - Covid-19. It's no surprise that the Covid-19 vaccines find a place in the list of top-selling pharmaceuticals.

biomarin nov29 Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa on November 24, 2021, Omicron cases have now been reported in at least 15 countries.

fda oct28 It's that time of month again when we take a look back at some of the regulatory news of October and look ahead to what's on the horizon for November.

pfizercovid sep30 The FDA approved 3 novel drugs in the month of September, bringing the total number of novel drug approvals so far this year to 39. Let's take a look at the biotech stocks facing FDA decision in October.

pfizer aug26 As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.

fda july23 27jul21 As July comes to a close, it's time to look back on some of the month's most important news and look forward to what August has in store. In a recent town hall meeting, the US President Joe Biden stated that he expected the FDA to fully approve the COVID-19 vaccines as soon as late August or early September.

fda jun23 As June draws to a close, it's time to take a look back on some of the month's top news stories related to FDA approval and look ahead to what July has in store.

Follow RTT